Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortInfusion that modestly slows early Alzheimer's.Most-used medicine for Alzheimer's symptoms.
Body systemBrain & NervesBrain & Nerves
Drug classAnti-amyloid antibodiesCholinesterase inhibitors
SupplyPrescription onlyPrescription only
Main usesEarly Alzheimer's disease (mild cognitive impairment or mild dementia) with confirmed amyloidMild to moderate Alzheimer's disease, Dementia with Lewy bodies, Parkinson's disease dementia (off-label in some countries)
How it worksHelps the brain's immune system clear sticky amyloid protein.Keeps more of a memory chemical (acetylcholine) available in the brain.
Starts working——
Half-life—About 70 hours
Typical adult dose10 mg/kg IV every 2 weeks; maintenance options include less frequent infusions or weekly injections.5 mg at night, increased to 10 mg after a month.
FormsIV infusion every 2 weeks, Subcutaneous autoinjector (maintenance)Tablet, Orodispersible tablet, Patch
Common side effectsInfusion reactions, Headache, ARIA on MRI (often without symptoms)Nausea, Diarrhoea, Vivid dreams, Muscle cramps, Insomnia
Serious side effectsBrain swelling or bleeding (ARIA), higher with two copies of APOE4, Serious bleeds with blood thinnersSlow heart rate and fainting, Stomach bleeding
Don't take if——
Alcohol——
PregnancyUsually avoidedNot studied.Use with cautionNot relevant to most users; no data.
Breastfeeding——
In use since20231996
Brand namesUnited States: Leqembi, Leqembi IqlikUnited Kingdom: LeqembiEurope: LeqembiUnited States: Aricept, Adlarity (patch)United Kingdom: AriceptIndia: Donep, Alzil, Aricep
Legal status——
ATC code—N06DA02

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker